Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients

Name: Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
Published: 2022
License: Public Domain

National Cancer Centre, Singapore · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

hepatocellular-carcinoma

locally advanced hepatocellular carcinoma, sirt-y90, atezolizumab plus bevacizumab, hepatocellular carcinoma, sir-sphere, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients

Related documents